The United States has approved the first direct-acting drug for the treatment of late-stage pancreatic adenocarcinoma, one of the most aggressive forms of cancer. The new medication has demonstrated a twofold improvement in survival rates compared to standard chemotherapy.
New research shows that improper folding of the proinsulin protein in pancreatic beta cells contributes to the development of type 2 diabetes. Enhancing the mechanisms responsible for correct protein folding may become a promising direction for future therapies.
A new study has shown that the risk of developing certain types of cancer depends not so much on the total amount of body fat, but rather on where it is distributed in the body. Visceral and liver fat are considered especially dangerous.
A new study on mice has shown that long-term adherence to the keto diet may lead to metabolic disorders, as well as liver and pancreatic problems. Experts recommend exercising caution when considering prolonged use of this diet.